Project Grant CLSS00000059474

The federal Project Grant award with ID DP2DA062283 was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The $2,542,500 grant, awarded on September 1, 2024, will support the development of novel econometric methods and a unified framework for integrating real-world evidence (RWE) to analyze inconclusive randomized controlled trials (RCTs) focused on opioid use disorder (OUD) treatments. The project, to be conducted by Weill...

Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded $709,085 to the University of Colorado-Denver under the Drug Use and Addiction Research Programs (CFDA 93.279) on April 1, 2026, for an implementation trial extending through January 31, 2031. This Project Grant supports research to facilitate in-hospital opioid treatment program (OTP) intakes and improve hospital-to-OTP linkage outcomes for hospitalized patients with opioid use disorder (OUD). The research addresses...

Federal Grant Award Summary Oregon Health & Science University received a $906,124 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), effective September 1, 2025, through May 31, 2030. The research initiative focuses on understanding the cellular mechanisms underlying opioid tolerance through investigation of mu opioid receptor (MOR) trafficking, endosomal recycling, and the retromer protein complex. The project...

Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded $402,205 to the University of Nevada, Reno, through its Drug Use and Addiction Research Programs (CFDA 93.279) to conduct a two-year research study examining opioid use disorder (OUD) treatment access for dual Medicare and Medicaid beneficiaries. The research project, active from May 1, 2026 through April 30, 2028, will analyze claims and enrollment data from 2021-2024 to assess whether enrollment in Dual Special Needs Plans...

Federal Grant Award Summary The Research Foundation For Mental Hygiene, Inc., through its New York State Psychiatric Institute division, received a $450,175 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct an eight-week clinical research study investigating sphenopalatine ganglion (SPG) blocks as an adjunctive treatment for opioid use disorder (OUD). The award, effective May 15, 2026, through April...

Federal Grant Award Summary The Naloxone Project (TNP) received a $600,000 project grant award from the Federal Office of Rural Health Policy under the Rural Healthcare Services Programs (CFDA 93.912) to implement the Colorado Change project, addressing the opioid overdose crisis in Colorado's rural communities. The grant, effective September 1, 2025 through August 31, 2026, will enhance naloxone (overdose reversal medication) distribution and overdose screening services across 16 key rural...

Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded Tufts University School of Medicine a $652,766 Project Grant effective May 1, 2026, through February 28, 2031, under the Drug Use and Addiction Research Programs (CFDA 93.279). The award supports research on Extended-Release Opioid Use Disorder Treatment in Massachusetts (EXOUD-MASS), a study designed to understand optimal integration of extended-release buprenorphine (XRB) formulations into the comprehensive menu of...

Federal Grant Award Summary Albert Einstein College of Medicine received a $252,000 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded May 1, 2026, with completion targeted for March 31, 2029. The award funds the DEMURE Trial, a 12-week pilot randomized controlled trial investigating the combined use of dronabinol (synthetic delta-9-tetrahydrocannabinol) and Epidiolex (cannabidiol) as adjunctive treatments to...

Opos.ai, Inc. received a $267,557 Project Grant award from the National Science Foundation on December 1, 2021 to develop an opioid taper clinical decision support tool for use in primary care outpatient settings. The tool will assist primary care providers in safely tapering patients off opioid medications and is intended to address the ongoing public health crisis of opioid addiction and overdose. This award falls under the NSF's Technology, Innovation, and Partnerships program (CFDA...

Federal Grant Award Summary Boston Medical Center Corporation received a $2.67 million Project Grant from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279) for "The LINK Intervention: Using Informatics and Implementation Science to Reduce Missed Opportunities to Prevent Opioid Overdose and HIV Infection." The award, effective May 1, 2026, through April 30, 2030, funds the development and implementation of LINK, a system-wide...